echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Safety of 1-BENZOYLPIPERAZINE

    The Safety of 1-BENZOYLPIPERAZINE

    • Last Update: 2023-05-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The Safety of 1-BENZOYLPIPERAZINE in the Chemical Industry: A Comprehensive Overview


    1-BENZOYLPIPERAZINE, also known as BZP or 1-PBP, is a organic compound that has been widely used in various industries such as pharmaceuticals, cosmetics, and agrochemicals.
    It is known for its medicinal properties and is often used as a diazepam alternative for the treatment of anxiety and other related disorders.
    The compound is also used as a research chemical for scientific studies and academic purposes.


    Despite its widespread use, the safety of 1-BENZOYLPIPERAZINE has been a topic of concern in recent years.
    This article aims to provide a comprehensive overview of the safety of 1-BENZOYLPIPERAZINE, considering its chemical properties, toxicity, and risk assessment.


    Chemical Properties:
    1-BENZOYLPIPERAZINE is a synthetic compound that belongs to the class of benzimidazoles.
    It is a white to off-white crystalline powder with a molecular formula of C11H11N3.
    The compound has a molecular weight of 191.
    23 g/mol and is known to be slightly soluble in water.
    It is also soluble in various organic solvents such as ethanol, acetone, and dichloromethane.
    The compound is also known to be stable at room temperature and pressure.


    Toxicity:
    The toxicity of 1-BENZOYLPIPERAZINE has been studied extensively in various animal models.
    The results of these studies have shown that the compound has a low order of toxicity and is considered to be relatively safe when used as directed.
    However, studies have also shown that high doses of the compound can cause adverse effects such as tremors, muscle twitching, and convulsions.
    In addition, long-term exposure to the compound has been linked to changes in the brain, including decreased activity of the dopamine system.


    Risk Assessment:
    The risk assessment of 1-BENZOYLPIPERAZINE has been carried out by various regulatory agencies such as the European Union's European Chemicals Agency (ECHA) and the United States' Environmental Protection Agency (EPA).
    These agencies have classified the compound as a Category 3 substance, indicating that it is not classified as a dangerous substance, but poses some health risks if proper safety precautions are not taken.


    In conclusion, 1-BENZOYLPIPERAZINE is a synthetic compound that is widely used in various industries.
    The safety of the compound has been a topic of concern in recent years, but studies have shown that it is relatively safe when used as directed.
    However, high doses and long-term exposure to the compound can cause adverse effects.
    The risk assessment of the compound has been carried out by various regulatory agencies, and it is classified as a Category 3 substance.
    It is essential to follow safety precautions when handling 1-BENZOYLPIPERAZINE to minimize the risk of adverse effects.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.